112,850 Shares in LHC Group (LHCG) Acquired by Castleark Management LLC

Castleark Management LLC purchased a new stake in shares of LHC Group (NASDAQ:LHCG) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 112,850 shares of the health services provider’s stock, valued at approximately $7,661,000. Castleark Management LLC owned about 0.62% of LHC Group as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Alps Advisors Inc. increased its position in shares of LHC Group by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 9,449 shares of the health services provider’s stock valued at $641,000 after purchasing an additional 24 shares during the last quarter. Federated Investors Inc. PA increased its position in shares of LHC Group by 4.2% during the 2nd quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after purchasing an additional 66 shares during the last quarter. Arizona State Retirement System increased its position in shares of LHC Group by 1.3% during the 2nd quarter. Arizona State Retirement System now owns 7,818 shares of the health services provider’s stock valued at $531,000 after purchasing an additional 100 shares during the last quarter. Victory Capital Management Inc. increased its position in shares of LHC Group by 0.3% during the 2nd quarter. Victory Capital Management Inc. now owns 48,920 shares of the health services provider’s stock valued at $3,321,000 after purchasing an additional 142 shares during the last quarter. Finally, Texas Permanent School Fund increased its position in shares of LHC Group by 1.4% during the 2nd quarter. Texas Permanent School Fund now owns 10,944 shares of the health services provider’s stock valued at $743,000 after purchasing an additional 153 shares during the last quarter. 85.93% of the stock is owned by hedge funds and other institutional investors.

In other news, COO Donald Dwayne Stelly sold 2,650 shares of the business’s stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $65.34, for a total value of $173,151.00. Following the completion of the sale, the chief operating officer now directly owns 109,235 shares in the company, valued at $7,137,414.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 14.80% of the stock is owned by insiders.

Shares of LHC Group (NASDAQ LHCG) traded down 0.39% on Friday, hitting $65.97. The company had a trading volume of 22,076 shares. LHC Group has a 52 week low of $32.04 and a 52 week high of $73.85. The company has a market capitalization of $1.21 billion, a price-to-earnings ratio of 29.19 and a beta of 0.76. The stock’s 50-day moving average is $66.42 and its 200 day moving average is $62.10.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Wednesday, August 2nd. The health services provider reported $0.63 EPS for the quarter, beating the Zacks’ consensus estimate of $0.54 by $0.09. The business had revenue of $260.20 million during the quarter, compared to analysts’ expectations of $254.10 million. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The business’s revenue was up 15.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.52 earnings per share. Equities analysts expect that LHC Group will post $2.39 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by Markets Daily and is the property of of Markets Daily. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The legal version of this piece of content can be read at https://www.themarketsdaily.com/2017/10/13/112850-shares-in-lhc-group-lhcg-acquired-by-castleark-management-llc.html.

Several research firms have recently commented on LHCG. Zacks Investment Research lowered shares of LHC Group from a “buy” rating to a “hold” rating in a research report on Wednesday, October 4th. Robert W. Baird reaffirmed a “hold” rating and set a $63.00 price target on shares of LHC Group in a research report on Tuesday, September 12th. Royal Bank Of Canada reaffirmed a “buy” rating and set a $70.00 price target on shares of LHC Group in a research report on Wednesday, September 6th. Bank of America Corporation began coverage on shares of LHC Group in a research report on Monday, August 21st. They set a “buy” rating and a $76.00 price target for the company. Finally, BidaskClub raised shares of LHC Group from a “hold” rating to a “buy” rating in a research report on Friday, August 18th. Two research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $66.60.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply